• レポートコード:QYR2104Z6201 • 出版社/出版日:QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、92ページ • 納品方法:Eメール(納期:3日) • 産業分類:医療 |
Single User | ¥565,500 (USD3,900) | ▷ お問い合わせ |
Multi User/Five User | ¥848,250 (USD5,850) | ▷ お問い合わせ |
Enterprise License(同一法人内共有可) | ¥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、部位別ドラッグデリバリーのグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(リポソームドキソルビシン、リポソームアムホテリシンB、リポソームパクリタキセル、その他)、用途別市場規模(真菌感染症治療、がん・腫瘍治療、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。 ・市場概要 ・部位別ドラッグデリバリーの市場動向 ・企業の競争状況、市場シェア ・部位別ドラッグデリバリーの種類別市場規模(リポソームドキソルビシン、リポソームアムホテリシンB、リポソームパクリタキセル、その他) ・部位別ドラッグデリバリーの用途別市場規模(真菌感染症治療、がん・腫瘍治療、その他) ・部位別ドラッグデリバリーの北米市場規模2016-2027(アメリカ、カナダ) ・部位別ドラッグデリバリーのヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等) ・部位別ドラッグデリバリーのアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等) ・部位別ドラッグデリバリーの中南米市場規模2016-2027(メキシコ、ブラジル) ・部位別ドラッグデリバリーの中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等) ・主要企業情報(Johnson & Johnson、Gilead Sciences、Pacira、Sun Pharmaceutical、Luye Pharma、Sigma-Tau Group、Fudan-Zhangjiang、Teva Pharmaceutical、CSPC、Novartis、Kingond Pharm) ・結論 |
The selective delivery of chemotherapeutic agents to their site of action should increase therapeutic effectiveness and limit side effects. Most drug therapies currently available, however, exhibit little, if any specificity. Many times, a drug has limited or no access to its intended site of action or is prematurely metabolized or excreted. In other instances, the drug travels rather freely throughout the body and not only acts on the desired target tissues but also causes undesirable effects on nontarget tissues. This lack of target specificity is attributable, for the most part, to the formidable barriers that the body presents to the successful delivery of a drug from its site of administration to its site of action: a drug normally encounters or must by pass various molecules, enzymes, cells, membranes, and organs before reaching its designated target.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Site-Specific Drug Delivery in US$ by following Product Segments.: Liposomal Doxorubicin, Liposomal Amphoteracin B, Liposomal Paclitaxel and other.
Company profiles are primarily based on public domain information including company
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Market Analysis and Insights: Global Site-Specific Drug Delivery Market
The global Site-Specific Drug Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Site-Specific Drug Delivery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Site-Specific Drug Delivery market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Site-Specific Drug Delivery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Site-Specific Drug Delivery market.
Global Site-Specific Drug Delivery Scope and Market Size
Site-Specific Drug Delivery market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Site-Specific Drug Delivery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Liposomal Doxorubicin
Liposomal Amphoteracin B
Liposomal Paclitaxel
Other
Segment by Application
Fungal Infection Therapy
Cancer & Tumor Therapy
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Site-Specific Drug Delivery Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Liposomal Doxorubicin
1.2.3 Liposomal Amphoteracin B
1.2.4 Liposomal Paclitaxel
1.2.5 Other
1.3 Market by Application
1.3.1 Global Site-Specific Drug Delivery Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Fungal Infection Therapy
1.3.3 Cancer & Tumor Therapy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Site-Specific Drug Delivery Market Perspective (2016-2027)
2.2 Site-Specific Drug Delivery Growth Trends by Regions
2.2.1 Site-Specific Drug Delivery Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Site-Specific Drug Delivery Historic Market Share by Regions (2016-2021)
2.2.3 Site-Specific Drug Delivery Forecasted Market Size by Regions (2022-2027)
2.3 Site-Specific Drug Delivery Industry Dynamic
2.3.1 Site-Specific Drug Delivery Market Trends
2.3.2 Site-Specific Drug Delivery Market Drivers
2.3.3 Site-Specific Drug Delivery Market Challenges
2.3.4 Site-Specific Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Site-Specific Drug Delivery Players by Revenue
3.1.1 Global Top Site-Specific Drug Delivery Players by Revenue (2016-2021)
3.1.2 Global Site-Specific Drug Delivery Revenue Market Share by Players (2016-2021)
3.2 Global Site-Specific Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Site-Specific Drug Delivery Revenue
3.4 Global Site-Specific Drug Delivery Market Concentration Ratio
3.4.1 Global Site-Specific Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Site-Specific Drug Delivery Revenue in 2020
3.5 Site-Specific Drug Delivery Key Players Head office and Area Served
3.6 Key Players Site-Specific Drug Delivery Product Solution and Service
3.7 Date of Enter into Site-Specific Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Site-Specific Drug Delivery Breakdown Data by Type
4.1 Global Site-Specific Drug Delivery Historic Market Size by Type (2016-2021)
4.2 Global Site-Specific Drug Delivery Forecasted Market Size by Type (2022-2027)
5 Site-Specific Drug Delivery Breakdown Data by Application
5.1 Global Site-Specific Drug Delivery Historic Market Size by Application (2016-2021)
5.2 Global Site-Specific Drug Delivery Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Site-Specific Drug Delivery Market Size (2016-2027)
6.2 North America Site-Specific Drug Delivery Market Size by Type
6.2.1 North America Site-Specific Drug Delivery Market Size by Type (2016-2021)
6.2.2 North America Site-Specific Drug Delivery Market Size by Type (2022-2027)
6.2.3 North America Site-Specific Drug Delivery Market Size by Type (2016-2027)
6.3 North America Site-Specific Drug Delivery Market Size by Application
6.3.1 North America Site-Specific Drug Delivery Market Size by Application (2016-2021)
6.3.2 North America Site-Specific Drug Delivery Market Size by Application (2022-2027)
6.3.3 North America Site-Specific Drug Delivery Market Size by Application (2016-2027)
6.4 North America Site-Specific Drug Delivery Market Size by Country
6.4.1 North America Site-Specific Drug Delivery Market Size by Country (2016-2021)
6.4.2 North America Site-Specific Drug Delivery Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Site-Specific Drug Delivery Market Size (2016-2027)
7.2 Europe Site-Specific Drug Delivery Market Size by Type
7.2.1 Europe Site-Specific Drug Delivery Market Size by Type (2016-2021)
7.2.2 Europe Site-Specific Drug Delivery Market Size by Type (2022-2027)
7.2.3 Europe Site-Specific Drug Delivery Market Size by Type (2016-2027)
7.3 Europe Site-Specific Drug Delivery Market Size by Application
7.3.1 Europe Site-Specific Drug Delivery Market Size by Application (2016-2021)
7.3.2 Europe Site-Specific Drug Delivery Market Size by Application (2022-2027)
7.3.3 Europe Site-Specific Drug Delivery Market Size by Application (2016-2027)
7.4 Europe Site-Specific Drug Delivery Market Size by Country
7.4.1 Europe Site-Specific Drug Delivery Market Size by Country (2016-2021)
7.4.2 Europe Site-Specific Drug Delivery Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Site-Specific Drug Delivery Market Size (2016-2027)
8.2 Asia-Pacific Site-Specific Drug Delivery Market Size by Type
8.2.1 Asia-Pacific Site-Specific Drug Delivery Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Site-Specific Drug Delivery Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Site-Specific Drug Delivery Market Size by Type (2016-2027)
8.3 Asia-Pacific Site-Specific Drug Delivery Market Size by Application
8.3.1 Asia-Pacific Site-Specific Drug Delivery Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Site-Specific Drug Delivery Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Site-Specific Drug Delivery Market Size by Application (2016-2027)
8.4 Asia-Pacific Site-Specific Drug Delivery Market Size by Region
8.4.1 Asia-Pacific Site-Specific Drug Delivery Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Site-Specific Drug Delivery Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Site-Specific Drug Delivery Market Size (2016-2027)
9.2 Latin America Site-Specific Drug Delivery Market Size by Type
9.2.1 Latin America Site-Specific Drug Delivery Market Size by Type (2016-2021)
9.2.2 Latin America Site-Specific Drug Delivery Market Size by Type (2022-2027)
9.2.3 Latin America Site-Specific Drug Delivery Market Size by Type (2016-2027)
9.3 Latin America Site-Specific Drug Delivery Market Size by Application
9.3.1 Latin America Site-Specific Drug Delivery Market Size by Application (2016-2021)
9.3.2 Latin America Site-Specific Drug Delivery Market Size by Application (2022-2027)
9.3.3 Latin America Site-Specific Drug Delivery Market Size by Application (2016-2027)
9.4 Latin America Site-Specific Drug Delivery Market Size by Country
9.4.1 Latin America Site-Specific Drug Delivery Market Size by Country (2016-2021)
9.4.2 Latin America Site-Specific Drug Delivery Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Site-Specific Drug Delivery Market Size (2016-2027)
10.2 Middle East & Africa Site-Specific Drug Delivery Market Size by Type
10.2.1 Middle East & Africa Site-Specific Drug Delivery Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Site-Specific Drug Delivery Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Site-Specific Drug Delivery Market Size by Type (2016-2027)
10.3 Middle East & Africa Site-Specific Drug Delivery Market Size by Application
10.3.1 Middle East & Africa Site-Specific Drug Delivery Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Site-Specific Drug Delivery Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Site-Specific Drug Delivery Market Size by Application (2016-2027)
10.4 Middle East & Africa Site-Specific Drug Delivery Market Size by Country
10.4.1 Middle East & Africa Site-Specific Drug Delivery Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Site-Specific Drug Delivery Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Site-Specific Drug Delivery Introduction
11.1.4 Johnson & Johnson Revenue in Site-Specific Drug Delivery Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Details
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Site-Specific Drug Delivery Introduction
11.2.4 Gilead Sciences Revenue in Site-Specific Drug Delivery Business (2016-2021)
11.2.5 Gilead Sciences Recent Development
11.3 Pacira
11.3.1 Pacira Company Details
11.3.2 Pacira Business Overview
11.3.3 Pacira Site-Specific Drug Delivery Introduction
11.3.4 Pacira Revenue in Site-Specific Drug Delivery Business (2016-2021)
11.3.5 Pacira Recent Development
11.4 Sun Pharmaceutical
11.4.1 Sun Pharmaceutical Company Details
11.4.2 Sun Pharmaceutical Business Overview
11.4.3 Sun Pharmaceutical Site-Specific Drug Delivery Introduction
11.4.4 Sun Pharmaceutical Revenue in Site-Specific Drug Delivery Business (2016-2021)
11.4.5 Sun Pharmaceutical Recent Development
11.5 Luye Pharma
11.5.1 Luye Pharma Company Details
11.5.2 Luye Pharma Business Overview
11.5.3 Luye Pharma Site-Specific Drug Delivery Introduction
11.5.4 Luye Pharma Revenue in Site-Specific Drug Delivery Business (2016-2021)
11.5.5 Luye Pharma Recent Development
11.6 Sigma-Tau Group
11.6.1 Sigma-Tau Group Company Details
11.6.2 Sigma-Tau Group Business Overview
11.6.3 Sigma-Tau Group Site-Specific Drug Delivery Introduction
11.6.4 Sigma-Tau Group Revenue in Site-Specific Drug Delivery Business (2016-2021)
11.6.5 Sigma-Tau Group Recent Development
11.7 Fudan-Zhangjiang
11.7.1 Fudan-Zhangjiang Company Details
11.7.2 Fudan-Zhangjiang Business Overview
11.7.3 Fudan-Zhangjiang Site-Specific Drug Delivery Introduction
11.7.4 Fudan-Zhangjiang Revenue in Site-Specific Drug Delivery Business (2016-2021)
11.7.5 Fudan-Zhangjiang Recent Development
11.8 Teva Pharmaceutical
11.8.1 Teva Pharmaceutical Company Details
11.8.2 Teva Pharmaceutical Business Overview
11.8.3 Teva Pharmaceutical Site-Specific Drug Delivery Introduction
11.8.4 Teva Pharmaceutical Revenue in Site-Specific Drug Delivery Business (2016-2021)
11.8.5 Teva Pharmaceutical Recent Development
11.9 CSPC
11.9.1 CSPC Company Details
11.9.2 CSPC Business Overview
11.9.3 CSPC Site-Specific Drug Delivery Introduction
11.9.4 CSPC Revenue in Site-Specific Drug Delivery Business (2016-2021)
11.9.5 CSPC Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Site-Specific Drug Delivery Introduction
11.10.4 Novartis Revenue in Site-Specific Drug Delivery Business (2016-2021)
11.10.5 Novartis Recent Development
11.11 Kingond Pharm
11.11.1 Kingond Pharm Company Details
11.11.2 Kingond Pharm Business Overview
11.11.3 Kingond Pharm Site-Specific Drug Delivery Introduction
11.11.4 Kingond Pharm Revenue in Site-Specific Drug Delivery Business (2016-2021)
11.11.5 Kingond Pharm Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Site-Specific Drug Delivery Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Liposomal Doxorubicin
Table 3. Key Players of Liposomal Amphoteracin B
Table 4. Key Players of Liposomal Paclitaxel
Table 5. Key Players of Other
Table 6. Global Site-Specific Drug Delivery Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Site-Specific Drug Delivery Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Site-Specific Drug Delivery Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Site-Specific Drug Delivery Market Share by Regions (2016-2021)
Table 10. Global Site-Specific Drug Delivery Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Site-Specific Drug Delivery Market Share by Regions (2022-2027)
Table 12. Site-Specific Drug Delivery Market Trends
Table 13. Site-Specific Drug Delivery Market Drivers
Table 14. Site-Specific Drug Delivery Market Challenges
Table 15. Site-Specific Drug Delivery Market Restraints
Table 16. Global Site-Specific Drug Delivery Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Site-Specific Drug Delivery Market Share by Players (2016-2021)
Table 18. Global Top Site-Specific Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Site-Specific Drug Delivery as of 2020)
Table 19. Ranking of Global Top Site-Specific Drug Delivery Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Site-Specific Drug Delivery Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Site-Specific Drug Delivery Product Solution and Service
Table 23. Date of Enter into Site-Specific Drug Delivery Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Site-Specific Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Site-Specific Drug Delivery Revenue Market Share by Type (2016-2021)
Table 27. Global Site-Specific Drug Delivery Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Site-Specific Drug Delivery Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Site-Specific Drug Delivery Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Site-Specific Drug Delivery Revenue Market Share by Application (2016-2021)
Table 31. Global Site-Specific Drug Delivery Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Site-Specific Drug Delivery Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Site-Specific Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Site-Specific Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Site-Specific Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Site-Specific Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Site-Specific Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Site-Specific Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Site-Specific Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Site-Specific Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Site-Specific Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Site-Specific Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Site-Specific Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Site-Specific Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Site-Specific Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Site-Specific Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Site-Specific Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Site-Specific Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Site-Specific Drug Delivery Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Site-Specific Drug Delivery Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Site-Specific Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Site-Specific Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Site-Specific Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Site-Specific Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Site-Specific Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Site-Specific Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Site-Specific Drug Delivery Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Site-Specific Drug Delivery Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Site-Specific Drug Delivery Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Site-Specific Drug Delivery Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Site-Specific Drug Delivery Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Site-Specific Drug Delivery Market Size by Country (2022-2027) & (US$ Million)
Table 63. Johnson & Johnson Company Details
Table 64. Johnson & Johnson Business Overview
Table 65. Johnson & Johnson Site-Specific Drug Delivery Product
Table 66. Johnson & Johnson Revenue in Site-Specific Drug Delivery Business (2016-2021) & (US$ Million)
Table 67. Johnson & Johnson Recent Development
Table 68. Gilead Sciences Company Details
Table 69. Gilead Sciences Business Overview
Table 70. Gilead Sciences Site-Specific Drug Delivery Product
Table 71. Gilead Sciences Revenue in Site-Specific Drug Delivery Business (2016-2021) & (US$ Million)
Table 72. Gilead Sciences Recent Development
Table 73. Pacira Company Details
Table 74. Pacira Business Overview
Table 75. Pacira Site-Specific Drug Delivery Product
Table 76. Pacira Revenue in Site-Specific Drug Delivery Business (2016-2021) & (US$ Million)
Table 77. Pacira Recent Development
Table 78. Sun Pharmaceutical Company Details
Table 79. Sun Pharmaceutical Business Overview
Table 80. Sun Pharmaceutical Site-Specific Drug Delivery Product
Table 81. Sun Pharmaceutical Revenue in Site-Specific Drug Delivery Business (2016-2021) & (US$ Million)
Table 82. Sun Pharmaceutical Recent Development
Table 83. Luye Pharma Company Details
Table 84. Luye Pharma Business Overview
Table 85. Luye Pharma Site-Specific Drug Delivery Product
Table 86. Luye Pharma Revenue in Site-Specific Drug Delivery Business (2016-2021) & (US$ Million)
Table 87. Luye Pharma Recent Development
Table 88. Sigma-Tau Group Company Details
Table 89. Sigma-Tau Group Business Overview
Table 90. Sigma-Tau Group Site-Specific Drug Delivery Product
Table 91. Sigma-Tau Group Revenue in Site-Specific Drug Delivery Business (2016-2021) & (US$ Million)
Table 92. Sigma-Tau Group Recent Development
Table 93. Fudan-Zhangjiang Company Details
Table 94. Fudan-Zhangjiang Business Overview
Table 95. Fudan-Zhangjiang Site-Specific Drug Delivery Product
Table 96. Fudan-Zhangjiang Revenue in Site-Specific Drug Delivery Business (2016-2021) & (US$ Million)
Table 97. Fudan-Zhangjiang Recent Development
Table 98. Teva Pharmaceutical Company Details
Table 99. Teva Pharmaceutical Business Overview
Table 100. Teva Pharmaceutical Revenue in Site-Specific Drug Delivery Business (2016-2021) & (US$ Million)
Table 101. Teva Pharmaceutical Recent Development
Table 102. CSPC Company Details
Table 103. CSPC Business Overview
Table 104. CSPC Site-Specific Drug Delivery Product
Table 105. CSPC Revenue in Site-Specific Drug Delivery Business (2016-2021) & (US$ Million)
Table 106. CSPC Recent Development
Table 107. Novartis Company Details
Table 108. Novartis Business Overview
Table 109. Novartis Site-Specific Drug Delivery Product
Table 110. Novartis Revenue in Site-Specific Drug Delivery Business (2016-2021) & (US$ Million)
Table 111. Novartis Recent Development
Table 112. Kingond Pharm Company Details
Table 113. Kingond Pharm Business Overview
Table 114. Kingond Pharm Site-Specific Drug Delivery Product
Table 115. Kingond Pharm Revenue in Site-Specific Drug Delivery Business (2016-2021) & (US$ Million)
Table 116. Kingond Pharm Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Site-Specific Drug Delivery Market Share by Type: 2020 VS 2027
Figure 2. Liposomal Doxorubicin Features
Figure 3. Liposomal Amphoteracin B Features
Figure 4. Liposomal Paclitaxel Features
Figure 5. Other Features
Figure 6. Global Site-Specific Drug Delivery Market Share by Application: 2020 VS 2027
Figure 7. Fungal Infection Therapy Case Studies
Figure 8. Cancer & Tumor Therapy Case Studies
Figure 9. Other Case Studies
Figure 10. Site-Specific Drug Delivery Report Years Considered
Figure 11. Global Site-Specific Drug Delivery Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Site-Specific Drug Delivery Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Site-Specific Drug Delivery Market Share by Regions: 2020 VS 2027
Figure 14. Global Site-Specific Drug Delivery Market Share by Regions (2022-2027)
Figure 15. Global Site-Specific Drug Delivery Market Share by Players in 2020
Figure 16. Global Top Site-Specific Drug Delivery Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Site-Specific Drug Delivery as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Site-Specific Drug Delivery Revenue in 2020
Figure 18. Global Site-Specific Drug Delivery Revenue Market Share by Type (2016-2021)
Figure 19. Global Site-Specific Drug Delivery Revenue Market Share by Type (2022-2027)
Figure 20. North America Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Site-Specific Drug Delivery Market Share by Type (2016-2027)
Figure 22. North America Site-Specific Drug Delivery Market Share by Application (2016-2027)
Figure 23. North America Site-Specific Drug Delivery Market Share by Country (2016-2027)
Figure 24. United States Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Site-Specific Drug Delivery Market Share by Type (2016-2027)
Figure 28. Europe Site-Specific Drug Delivery Market Share by Application (2016-2027)
Figure 29. Europe Site-Specific Drug Delivery Market Share by Country (2016-2027)
Figure 30. Germany Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Site-Specific Drug Delivery Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Site-Specific Drug Delivery Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Site-Specific Drug Delivery Market Share by Region (2016-2027)
Figure 40. China Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Site-Specific Drug Delivery Market Share by Type (2016-2027)
Figure 48. Latin America Site-Specific Drug Delivery Market Share by Application (2016-2027)
Figure 49. Latin America Site-Specific Drug Delivery Market Share by Country (2016-2027)
Figure 50. Mexico Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Site-Specific Drug Delivery Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Site-Specific Drug Delivery Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Site-Specific Drug Delivery Market Share by Country (2016-2027)
Figure 56. Turkey Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Site-Specific Drug Delivery Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Johnson & Johnson Revenue Growth Rate in Site-Specific Drug Delivery Business (2016-2021)
Figure 60. Gilead Sciences Revenue Growth Rate in Site-Specific Drug Delivery Business (2016-2021)
Figure 61. Pacira Revenue Growth Rate in Site-Specific Drug Delivery Business (2016-2021)
Figure 62. Sun Pharmaceutical Revenue Growth Rate in Site-Specific Drug Delivery Business (2016-2021)
Figure 63. Luye Pharma Revenue Growth Rate in Site-Specific Drug Delivery Business (2016-2021)
Figure 64. Sigma-Tau Group Revenue Growth Rate in Site-Specific Drug Delivery Business (2016-2021)
Figure 65. Fudan-Zhangjiang Revenue Growth Rate in Site-Specific Drug Delivery Business (2016-2021)
Figure 66. Teva Pharmaceutical Revenue Growth Rate in Site-Specific Drug Delivery Business (2016-2021)
Figure 67. CSPC Revenue Growth Rate in Site-Specific Drug Delivery Business (2016-2021)
Figure 68. Novartis Revenue Growth Rate in Site-Specific Drug Delivery Business (2016-2021)
Figure 69. Kingond Pharm Revenue Growth Rate in Site-Specific Drug Delivery Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed